Senior Manager, QC Analytical Support & Investigations
Ocular Therapeutix
Senior Manager, QC Analytical Support & Investigations
Ocular Therapeutix
Hydrogel-based ocular drug delivery platform
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYX™. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care and position itself to become a leader in the ophthalmic space.
Outside of the ophthalmic realm and behind the doors of our headquarters in Bedford, MA, we strive to build a strong culture where employees can flourish and achieve their career goals. We encourage out of the box thinking, cross-functional collaboration, and creativity.
Position Summary
The Senior Manager, Quality Control – Analytical Support & Investigations is a senior technical leadership role responsible for providing investigation oversight and analytical problem-solving support across the Quality Control organization. The position serves as a central QC resource for Out-of-Specification (OOS), Out-of-Trend (OOT), laboratory deviations, atypical results, invalid assays, and other significant laboratory events associated with QC testing.
The Senior Manager is an individual contributor and partners closely with QC Chemistry, QC Microbiology, Raw Materials, Quality Assurance, Manufacturing, Analytical Development, and other technical functions to ensure laboratory investigations are scientifically sound, appropriately documented, completed in a timely manner, and supported by effective root-cause analysis and corrective and preventive actions.
Key Responsibilities
OOS, OOT & Laboratory Investigation Leadership
Deviation & CAPA Management
Investigation Trending & Metrics
Cross-Functional Investigation Support
Leadership & Organizational Responsibilities
Qualifications
#LI-LM1
Ocular Therapeutix is an Equal Opportunity Employer and complies with all applicable federal, state, and local laws regarding nondiscrimination. Ocular Therapeutix provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, or status as a veteran. For information on how Ocular Therapeutix collects, stores, and utilizes candidate information please see our privacy policy found at https://www.ocutx.com/privacy-policy/. For the Privacy Notice for California Job Applicants, please see CCPA Applicant Notice.
Salary Range 162000 - 175000 USD
Hydrogel-based ocular drug delivery platform
Ocular Therapeutix develops and commercializes eye therapies using a hydrogel-based drug-delivery platform. Its approach uses a biodegradable hydrogel that stays in the eye to release medicine over time, reducing the need for frequent eye drops or injections. The flagship product, DEXTENZA, is a corticosteroid insert placed by a physician after eye surgery to treat inflammation and pain, providing sustained local treatment. The company differentiates itself by offering a scalable platform that can be used to create a range of eye medications and devices for conditions such as glaucoma, retinal diseases (including wet AMD), and dry eye, rather than competing solely on one drug. Revenue comes from selling these products to physicians and surgical centers. The goal is to expand the hydrogel delivery platform into a broader pipeline of eye therapies to improve patient outcomes and adherence by delivering drugs where and when they are needed most.
Explore more opportunities at Ocular Therapeutix